Betamethasone dipropionate. a dermocorticoid
Durepaire, R.; Bourgeois-Spinasse, J.; Cardinne, A.; Edelson, Y.; Benazéraf, C.; Futchbaum, G.; Girard, J.; Rousselet, G.; Grupper, C.
La Nouvelle Presse Medicale 4(17): 1285-1286
1975
ISSN/ISBN: 0301-1518 PMID: 1153285 Document Number: 89402
Document emailed within 1 workday
Related Documents
Vacca, M.; De Natale, G.; Preziosi, P. 1980: The specific biological activity of the glucocorticoid betamethasone 17,21-dipropionate Il Farmaco; Edizione Pratica 35(4): 161-188Bjornberg, A.; Hellgren, L. 1976: Treatment of chronic discoid lupus erythematosus with betamethasone-17, 21-dipropionate Current Therapeutic Research 19(4): 442-443
Băiţan, M.; Gafiţanu, E.; Lionte, M.; Moisuc, L.ăc.ăm. 2010: Formulation of creams with betamethasone dipropionate: evaluation of chemical stability Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 114(2): 600-604
Toole, J.W.P. 2007: Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study Skin Therapy Letter 12(4): 1-3
Dyderski, S.ła.; Grześkowiak, E.; Szałek, E.; Mrzygłód, A. 2002: Pharmaceutical availability of betamethasone dipropionate and gentamicin sulfate from cream and ointment Acta Poloniae Pharmaceutica 59(2): 99-103
Van Dijk, E.; Bakkers, E.J.; Go, M.J.; Montnor, L.P.; Roessel, F.E.; van der Wateren, A.R.; Wuite, J. 1983: Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream Cutis 32(3): 284-285; 287
Sequira, J.; Berardi, M.; Chan, T.M.; Letarte, J.; Malchow, R.; Pramanick, B.; Wolkoff, H.N. 1991: Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment Clinical Therapeutics 13(6): 687-694
Bosco, G. 1985: Evaluation of the efficacy of and tolerance of betamethasone 17,21 dipropionate and salicylic acid in dermatoses of the scalp Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(2): Xxv-Xxvii
Băiţan, M.; Lionte, M.; Moisuc, Lăcrămioara.; Gafiţanu, E. 2011: Optimization of topical gels with betamethasone dipropionate: selection of gel forming and optimal cosolvent system Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(2): 601-605
Xing, C.; Xu, A. 2012: The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial Journal of Drugs in Dermatology: Jdd 11(10): E52-E54
Mizushima, Y.; Ishikawa, M. 1979: Effects of betamethasone 17, 21-dipropionate on activities of glycogen synthase and tyrosine aminotransferase in fetal rat liver in organ culture Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(8): 799-804
Wortzel, M.H. 1982: A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product Cutis 30(2): 258-261
Saffie, F.; Gordillo, H.; Gordillo, E.; Ballesteros, F. 1989: Intra-articular treatment of osteoarthrosis of the knee with betamethasone dipropionate and disodium phosphate. Non-controlled, open 5 years' experience Revista Medica de Chile 117(11): 1261-1266
Menter, A.; Abramovits, W.; Colón, L.E.; Johnson, L.A.; Gottschalk, R.W. 2009: Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis Journal of Drugs in Dermatology: Jdd 8(1): 52-57
Katz, H.I.; Bard, J.; Cole, G.W.; Fischer, S.; McCormick, G.E.; Medansky, R.S.; Nesbitt, L.T.; Rex, I.H. 1984: SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis Cutis 34(2): 183-188
Hellgren, L. 1976: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis Annals of Clinical Research 8(5): 317-319
Menter, A.; Gold, L.S.; Bukhalo, M.; Grekin, S.; Kempers, S.; Boyce, B.M.; Ganslandt, C.; Villumsen, J.; Lebwohl, M. 2013: Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial Journal of Drugs in Dermatology: Jdd 12(1): 92-98
Kircik, L.H. 2011: Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial Journal of Drugs in Dermatology: Jdd 10(8): 878-882
Leonardi, C.; Bagel, J.; Yamauchi, P.; Pariser, D.; Xu, Z.; Moller, A.; Osterdal, M.L.; Stein Gold, L. 2016: The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients with Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study Journal of Drugs in Dermatology: Jdd 15(8): 981-987
Silver, S.; Tuppal, R.; Gupta, A.K.; Clonier, F.; Olesen, M.; Leeder, R.; Taraska, V. 2013: Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial Journal of Drugs in Dermatology: Jdd 12(8): 882-887